Development and Validation of an UHPLC-MS/MS Method for Quantification of DMAG in Rat Plasma and Its Application in a Preliminary Pharmacokinetic Study in Thrombocytopenia Rats

<div>Mean plasma concentration-time profiles of normal rats (a) and thrombocytopenia rats (b) after intravenous administration of 2 mg/kg DMAG, and the integrated plasma concentration-time profiles of each group (c) ((<i>n</i>) = 6).</div>

Journal of Chemistry

fig5

Figure 5

Figure 5: Development and Validation of an UHPLC-MS/MS Method for Quantification of DMAG in Rat Plasma and Its Application in a Preliminary Pharmacokinetic Study in Thrombocytopenia Rats 

Figure 5 | Development and Validation of an UHPLC-MS/MS Method for Quantification of DMAG in Rat Plasma and Its Application in a Preliminary Pharmacokinetic Study in Thrombocytopenia Rats 